Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity
Yu-Chi Chiu, Shih‐Wei Lee, Chi‐Wei Liu, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0249944-e0249944
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Mechanisms coupling the mTOR pathway to chronic obstructive pulmonary disease (COPD) pathogenesis
Ankita Goyal, Vishal Chopra, Kranti Garg, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access | Times Cited: 2
Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study
Yu-Chi Chiu, Shih‐Wei Lee, Chi‐Wei Liu, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 49
Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease
Stanislav Kotlyarov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4768-4768
Open Access | Times Cited: 39
Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment
Mengdi Sun, Fang Lü, Donghua Yu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status
Anders Ørskov Rotevatn, Tomas Eagan, Solveig Tangedal, et al.
European Clinical Respiratory Journal (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Seabuckthorn Wuwei Pulvis attenuates chronic obstructive pulmonary disease in rat through gut microbiota-short chain fatty acids axis
Junmei Wang, Chunxiu Ren, Lingling Jin, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116591-116591
Closed Access | Times Cited: 21
Assessment of progression of pulmonary fibrosis based on metabonomics and analysis of intestinal microbiota
J. Liu, Hong-Bing Zhou, Wanfu Bai, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 201-217
Open Access | Times Cited: 6
Lung and Gut Microbiome in COPD
Efstathios Karakasidis, Ourania S. Kotsiou, Konstantinos I. Gourgoulianis
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 804-804
Open Access | Times Cited: 14
Genetic Insights into the Gut-Lung Axis: Mendelian Randomization Analysis on Gut Microbiota, Lung Function, and COPD
Zi-Xuan Cheng, Jian-lan Hua, Zhijun Jie, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 643-653
Open Access | Times Cited: 5
The Pleiotropic Role of Vitamin K in Multimorbidity of Chronic Obstructive Pulmonary Disease
Ianthe Piscaer, Rob Janssen, Frits M.E. Franssen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1261-1261
Open Access | Times Cited: 11
A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases
Cong Xu, Mengqi Hao, Xiaohu Zai, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 3
Closed Access | Times Cited: 4
Application of Microbiome-Based Therapies in Chronic Respiratory Diseases
Se Hee Lee, Jang Ho Lee, Sei Won Lee
The Journal of Microbiology (2024) Vol. 62, Iss. 3, pp. 201-216
Closed Access | Times Cited: 4
The role of gut-lung axis in COPD: Pathogenesis, immune response, and prospective treatment
Z. Song, Yifei Meng, Michael Fricker, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30612-e30612
Open Access | Times Cited: 4
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease
Xiaofan Song, Xina Dou, Jiajing Chang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
The synergistic link between sonic hedgehog signaling pathway and gut–lung axis: Its influential role toward chronic obstructive pulmonary disease progression
Nidhi Mahajan, Vishal Chopra, Kranti Garg, et al.
Developmental Dynamics (2025)
Open Access
Longitudinal dynamics of the nasopharyngeal microbiome in response to SARS-CoV-2 Omicron variant and HIV infection in Kenyan women and their children
Ayla Žuštra, Victoria R. Leonard, LaRinda A. Holland, et al.
mSystems (2025)
Open Access
Metabolomics in COPD
Joaquim Gea, César Jessé Enríquez-Rodríguez, Sergi Pascual-Guàrdia
Archivos de Bronconeumología (2023) Vol. 59, Iss. 5, pp. 311-321
Open Access | Times Cited: 10
First Exploration of the Altered Microbial Gut–Lung Axis in the Pathogenesis of Human Refractory Chronic Cough
Simone Baldi, Alessio Fabbrizzi, Leandro Di Gloria, et al.
Lung (2024) Vol. 202, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients
Vincent Laiman, Hsiao‐Chi Chuang, Yu‐Chun Lo, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Update on metabolomic findings in COPD patients
Joaquim Gea, César Jessé Enríquez-Rodríguez, Bella Agranovich, et al.
ERJ Open Research (2023) Vol. 9, Iss. 5, pp. 00180-2023
Open Access | Times Cited: 9
The Effect of Theaflavins on the Gut Microbiome and Metabolites in Diabetic Mice
Jun Wang, Yixin Qin, Jingjing Jiang, et al.
Foods (2023) Vol. 12, Iss. 20, pp. 3865-3865
Open Access | Times Cited: 8
Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets
Lei Wang, Pim J. Koelink, Johan Garssen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4058-4058
Open Access | Times Cited: 3
Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease
Radivoj Arežina, Tao Chen, Duolao Wang
International Journal of COPD (2023) Vol. Volume 18, pp. 447-457
Open Access | Times Cited: 7
The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis
Ziwei Kou, Kai Liu, Zhengtong Qiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease
Kuppan Gokulan, Manish Joshi, Sangeeta Khare, et al.
Current Opinion in Pulmonary Medicine (2021) Vol. 28, Iss. 2, pp. 134-138
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top